BLRX Message Board Post 10902806 | BioLineRx Ltd.
home / stock / blrx / blrx message board
mhunck
(investorshangout)
Posted on: Jan/17/2017 12:07:43
Source: investorshangout
https://investorshangout.com/post/view?id=4292524
chemist823: BLRX Phase 2 initiated. BioLineRx Announces Initiation of Immuno-Oncology Phase 2 Study to Investi
News, Short Squeeze, Breakout and More Instantly...
-
BioLineRx Announces Clinical Trial Agreement with St. Jude Children's Research Hospital, Inc. to Evaluate Motixafortide for CD34+ Hematopoietic Stem Cell (HSC) Mobilization For Gene Therapy Applications in Sickle Cell Disease (SCD) PR Newswire - Investigator-initiated study in...
-
Orkla ASA ADR (ORKLY) is expected to report for Q1 2024 Cosmos Health Inc. (COSM) is expected to report $-0.14 for Q1 2024 Basilea Pharmaceutica AG Registered Shares (BPMUF) is expected to report for Q1 2024 DCC Plc (DCCPF) is expected to report for Q4 2024 Datatec Ltd ADR (DTTLY)...
-
BioLineRx Announces Abstract on Pilot Study Data from Phase 2 Combination Clinical Trial Evaluating Motixafortide in First-Line Pancreatic Cancer (PDAC) at American Society of Clinical Oncology (ASCO) 2024 Annual Meeting PR Newswire New analysis of biopsy samples demonstrate...